Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
53.88
-0.20 (-0.37%)
At close: Oct 10, 2025, 4:00 PM EDT
53.86
-0.02 (-0.04%)
After-hours: Oct 10, 2025, 7:51 PM EDT
Akero Therapeutics Employees
Akero Therapeutics had 63 employees as of December 31, 2024. The number of employees increased by 7 or 12.50% compared to the previous year.
Employees
63
Change (1Y)
7
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$4,507,286
Market Cap
4.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63 | 7 | 12.50% |
Dec 31, 2023 | 56 | 17 | 43.59% |
Dec 31, 2022 | 39 | 5 | 14.71% |
Dec 31, 2021 | 34 | 12 | 54.55% |
Dec 31, 2020 | 22 | 8 | 57.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AKRO News
- 1 day ago - Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO - Business Wire
- 1 day ago - Akero: Novartis Acquisition Puts Focus On Unprecedented MASH Data With EFX - Seeking Alpha
- 2 days ago - Top Stock Movers Now: Delta Air Lines, PepsiCo, Akero Therapeutics, and More - Investopedia
- 2 days ago - Novo Nordisk to acquire Akero Therapeutics for its experimental liver disease drug - Fast Company
- 2 days ago - Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion - Benzinga
- 2 days ago - Akero Therapeutics soars after Novo Nordisk set for $5.2B cash acquisition - Invezz
- 2 days ago - Akero Therapeutics Stock Soars on Novo Nordisk Deal. - Barrons
- 2 days ago - Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease - Market Watch